Abstract:Objective To investigate the effectiveness of Jubei Mixture combined with imipenem and cilastatin sodium in the treatment of community-acquired pneumonia (CAP) with respiratory failure (RF) and its effect on inflammatory factors and blood gas indexes.Methods Eighty-six patients with CAP with RF admitted to our hospital from March 2021 to March 2024 were selected and randomly divided into 43 cases in the observation group and 43 cases in the control group using the odd-even number method. The control group was treated with imipenem and cilastatin sodium, and the observation group was additionally given Jubei Mixture. After 7 days of treatment, the two groups were compared in terms of blood gas indexes, lung function, inflammatory factors, cardiac and renal function, therapeutic efficacy and adverse reactions.Results The differences of partial pressure of oxygen, partial pressure of carbon dioxide, oxygenation index, peak expiratory flow, forced vital capacity, forced expiratory volume in 1 second, and levels of tumor necrosis factor-α and soluble triggering receptor expressed on myeloid cells-1 before and after treatment in the observation group were all greater than those in the control group (P < 0.05). The effective rate in the observation group was higher than that in the control group (P < 0.05). There was no significant difference in the incidence of total adverse reactions between the observation group and the control group (P > 0.05).Conclusion Jubei Mixture combined with imipenem and cilastatin sodium for the treatment of CAP with RF promotes the recovery of pulmonary function and demonstrates a favorable safety profile.